Brief: Mangoceuticals Says Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
07/11/2023 23:05
Nov 7 (Reuters) - Mangoceuticals Inc MGRX.O :
* GOT NOTICE OF DELISTING OR FAILURE TO SATISFY A CONTINUED
LISTING RULE OR STANDARD FROM NASDAQ
* CURRENTLY EVALUATING VARIOUS COURSES OF ACTION TO REGAIN
COMPLIANCE
* PLANS TO TIMELY SUBMIT ITS PLAN TO NASDAQ TO REGAIN
COMPLIANCE
WITH THE MINIMUM STOCKHOLDERS’ EQUITY REQUIREMENT
Source text for Eikon: ID:
Further company coverage: MGRX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Mangoceuticals
See all newsBrief: Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement On August 19
Brief: Mangoceuticals Inc.’S Merger Partner, Nuclea Energy, Inc., Enters Into Definitive Agreement To Acquire Moltex Energy’S Advanced Nuclear Technology Assets
NASDAQ RESUMED AT 10:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:30 AM
NASDAQ RESUMED AT 10:27 AM